Perrigo Co PLC (NYSE:PRGO)
$ 25.11 -0.3 (-1.18%) Market Cap: 3.43 Bil Enterprise Value: 6.99 Bil PE Ratio: 0 PB Ratio: 0.75 GF Score: 64/100

Perrigo Company PLC at RBC Global Healthcare Conference (Virtual) Transcript

May 20, 2020 / 03:30PM GMT
Release Date Price: $55.08 (+0.07%)
Randall S. Stanicky
RBC Capital Markets, Research Division - MD of Global Equity Research & Lead Analyst

All right. Thanks, everybody, for joining us for our next session. I'm Randall Stanicky, the pharmaceuticals analyst here at RBC Capital Markets. And our next company presenting is Perrigo. And with us is the CEO, Murray Kessler, who is in his second year at Perrigo as CEO, and we also have Ray Silcock, who's the company's CFO. And so what I want to do is just -- first, guys, thanks for joining us. We really appreciate having you as part of our conference here.

Questions & Answers

Randall S. Stanicky
RBC Capital Markets, Research Division - MD of Global Equity Research & Lead Analyst

And Murray, just to kick off, I think you can probably agree. I've not been afraid to push back on the story. And what we've been looking for, we've discussed that. But the business started to improve. You've been making changes. We've seen metrics starting to improve. And you add that to the setup as we enter the COVID-19 pandemic positioning. And we see the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot